The “Green Path” not only benefits the environment, but also companies
For Sanofi, a global biopharmaceutical company specialising in the areas of vaccines, immunology, cardiology and oncology, among others, human health is clearly at the forefront. Sanofi wants to protect, activate and support people struggling with health problems, allowing them to enjoy life to the full. In addition to direct support, other issues that affect health are also important, and so the state of the environment should be one of the main priorities. The modern technological solutions implemented by the company at its production plant in Rzeszow, which is one of 75 in the world, enable the responsible use of raw materials, reduction of waste production, a reduced carbon footprint and improvements in energy efficiency. Sanofi also aims to continuously increase the share of green energy in its production processes. The sum total of these activities translates into creating a greener place for all of us to live in.
Innovations on Polish soil
The production plant in Rzeszów, which was founded in 1985 and produces mainly medicines, has been operating in accordance with the ISO 14001 environmental management standard for 15 years, since it was first introduced. A modernisation of the plant was carried out several years ago, which brought a number of measurable benefits for the environment. The implementation of energy-saving technologies meant that in 2020 13% less energy was needed to produce one unit of a medicine or dermocosmetic than the year before. Solutions for reducing energy consumption include energy-efficient LED lighting in rooms, a computer system for controlling air conditioning and ventilation parameters, and the use of a 1300 kW heating boiler, which is less energy-consuming than conventional boilers. It is worth noting that in 2020, with a 12% increase in production, overall energy consumption fell by 3%.
The activities undertaken in Poland are part of Sanofi's global strategy aimed at fulfilling the key demand in the field of combating the climate crisis through reduction of greenhouse gas emissions. The company has set itself the ambitious goal of reducing emissions by 50% in 2025, compared to 2015. Already, thanks to the implementation of numerous innovations at every stage of production and management, we have achieved a 14.7% reduction in emissions (compared to the third quarter of 2019). In turn, the reduction in heat losses has made it possible to reduce CO2 emissions by 63.1 tonnes per year. Furthermore, the installation of EU7 filters on the plant's air conditioning units, which guarantee high air purity, ensures the absorption of up to 99% of particulates. The adaptations are not limited to the production plant either. The modernisation of the car fleet – replacing the 433 cars used by Sanofi's medical and pharmaceutical representatives on a daily basis – reduced the CO2 emissions associated with their business trips by 20%.
Continuous closure of the circuit
In an effort to improve the quality of waste segregation and reduce the amount of waste generated, the company has abandoned environmentally unfriendly disposable packaging. Plastic cups in coffee machines and water dispensers have been replaced by reusable ceramic cups (each employee received one, and additionally they were placed in common areas), as well as paper cups. Lunches previously served in plastic containers are now served in reusable containers (each employee received a set of three such containers). Plastic cutlery has also been replaced by metal, and wooden coffee stirrers have been introduced, mainly for the plant's guests. Providing water in plastic bottles has been discontinued in line with global trends. Printed magazine subscriptions were replaced by electronic subscriptions in order to reduce the amount of waste paper, and an electronic document flow was introduced throughout the company.
Opening up the recycling routes
Since 2020, Sanofi has been recycling used medicine blister packs in collaboration with an external company. Thanks to innovative methods, both the plastic and aluminium contained in medical blisters can be 100% recovered and recycled. Plastics, which previously would have become landfill waste, can now be reused to produce, among other things, rubbish bags, flower pots and garden furniture. This way, one of the main demands of a 'closed-loop' economy – the reuse of as many materials as possible – is realised.
Research shows that up to 90% of medical waste in the environment comes from consumers. It is therefore extremely important to educate people on the proper handling of used or outdated medicines. In response to this need, the Consumer Working Group of the Sustainable Development and Corporate Social Responsibility Team at the Ministry of Funds and Regional Policy, of which Sanofi is a member, has prepared the publication "Responsible Consumer – Health". It contains practical information on good habits related to the purchase, use and disposal of medicines. This initiative is part of the company's broader strategy emphasising support, awareness-raising and consumer education.
Without continuous innovation, the Closed-Loop Economy will remain an ecological dream, not an everyday reality
Interview with Marek Ruchała, Industrial Director of the Sanofi Group in Poland
Article prepared by TOGETAIR Editors on the basis of the materials provided by the partner.